Latest Insider Transactions at Sonnet Bio Therapeutics Holdings, Inc. (SONN)
This section provides a real-time view of insider transactions for Sonnet Bio Therapeutics Holdings, Inc. (SONN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sonnet BioTherapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sonnet BioTherapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 11
2025
|
John K. Cini Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+45.95%
|
-
|
|
Jul 11
2025
|
Susan Dexter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+45.34%
|
-
|
|
Jul 11
2025
|
Richard T Kenney Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+46.05%
|
-
|
|
Jul 11
2025
|
Nailesh Bhatt Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+48.67%
|
-
|
|
Jul 11
2025
|
Donald J. Griffith Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+49.08%
|
-
|
|
Jul 11
2025
|
Lori Mc Neill Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+47.65%
|
-
|
|
Jul 11
2025
|
Stephen J Mcandrew Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+48.21%
|
-
|
|
Jul 11
2025
|
Raghu Rao Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+47.22%
|
-
|
|
Dec 11
2023
|
John Harry Cross Iii Chief Financial Officer |
SELL
Grant, award, or other acquisition
|
Direct |
1,452
-47.76%
|
-
|
|
Dec 11
2023
|
Richard T Kenney Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,271
+48.05%
|
-
|
|
Dec 11
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,554
+33.51%
|
-
|
|
Dec 11
2023
|
Donald J. Griffith Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
317
+45.81%
|
-
|
|
Dec 11
2023
|
John K. Cini Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,888
+47.15%
|
-
|
|
Dec 11
2023
|
Raghu Rao Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
373
+13.67%
|
-
|
|
Dec 11
2023
|
Albert D. Dyrness Director |
BUY
Grant, award, or other acquisition
|
Direct |
373
+40.99%
|
-
|
|
Dec 11
2023
|
Lori Mc Neill Director |
BUY
Grant, award, or other acquisition
|
Direct |
373
+48.63%
|
-
|
|
Dec 11
2023
|
Susan Dexter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+46.91%
|
-
|
|
Dec 11
2023
|
Nailesh Bhatt Director |
BUY
Grant, award, or other acquisition
|
Direct |
373
+40.54%
|
-
|
|
Oct 27
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
34,375
+36.61%
|
-
|
|
Oct 27
2023
|
Raghu Rao Interim CEO |
BUY
Open market or private purchase
|
Direct |
15,625
+48.17%
|
-
|
|
Jul 11
2023
|
Albert D. Dyrness Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+46.85%
|
-
|
|
Jun 14
2023
|
Susan Dexter Chief Technical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+22.9%
|
$0
$0.7 P/Share
|
|
May 30
2023
|
Albert D. Dyrness Director |
BUY
Open market or private purchase
|
Direct |
23,255
+44.54%
|
$0
$0.47 P/Share
|
|
May 17
2023
|
Nailesh Bhatt Director |
BUY
Open market or private purchase
|
Direct |
25,000
+44.86%
|
$0
$0.23 P/Share
|
|
May 15
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
371,600
+40.18%
|
$0
$0.22 P/Share
|
|
Mar 15
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
60,000
+24.82%
|
$0
$0.58 P/Share
|
|
Feb 06
2023
|
John Harry Cross Iii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,960
-7.57%
|
$1,960
$1.06 P/Share
|
|
Feb 06
2023
|
Donald J. Griffith Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
497
-4.6%
|
$497
$1.04 P/Share
|
|
Jan 07
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
73,561
+37.67%
|
-
|
|
Jan 07
2023
|
Pankaj Mohan Chairman, President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
73,561
-60.43%
|
-
|
|
Jan 07
2023
|
John K. Cini Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,551
+31.54%
|
-
|
|
Jan 07
2023
|
John K. Cini Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,551
-46.07%
|
-
|
|
Jan 07
2023
|
Richard T Kenney Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,627
+44.56%
|
-
|
|
Jan 07
2023
|
Richard T Kenney Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,627
-80.38%
|
-
|
|
Jan 07
2023
|
Susan Dexter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,627
+38.2%
|
-
|
|
Jan 07
2023
|
Susan Dexter Chief Technical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,627
-61.8%
|
-
|
|
Dec 14
2022
|
Albert D. Dyrness Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,770
+10.88%
|
-
|
|
Dec 14
2022
|
Richard T Kenney Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,627
+18.46%
|
-
|
|
Dec 14
2022
|
Lori Mc Neill Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,770
+50.0%
|
-
|
|
Dec 14
2022
|
Nailesh Bhatt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,770
+10.76%
|
-
|
|
Dec 14
2022
|
John K. Cini Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,551
+5.44%
|
-
|
|
Dec 14
2022
|
John Harry Cross Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,519
+8.81%
|
-
|
|
Dec 14
2022
|
Pankaj Mohan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
74,205
+9.02%
|
-
|
|
Dec 14
2022
|
Susan Dexter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,627
+9.39%
|
-
|
|
Dec 14
2022
|
Raghu Rao Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,770
+12.6%
|
-
|
|
Dec 09
2022
|
Donald J. Griffith Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,214
+22.94%
|
-
|
|
Apr 08
2022
|
Donald J. Griffith Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,507
-4.07%
|
$0
$0.37 P/Share
|
|
Dec 15
2021
|
Nailesh Bhatt Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,152
+33.99%
|
-
|
|
Dec 15
2021
|
Albert D. Dyrness Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,152
+34.29%
|
-
|
|
Dec 15
2021
|
John Harry Cross Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,951
+31.56%
|
-
|